Literature DB >> 9526213

Revision of unicompartmental arthroplasty of the knee. Clinical and technical considerations.

G Chakrabarty1, J H Newman, C E Ackroyd.   

Abstract

In 73 unicompartmental arthroplasties of the knee that were revised, the major causes of failure were progression of arthritis and implant failure. The interval between the primary and revision averaged 56 months. Eighty-eight percent were revised to a variety of total condylar prostheses. Bone loss was classified by defect at the end of preparation. In 31 patients, there were none; in 17, the defect was in either the femur or the tibia; and in 25, there were defects in both the femur and the tibia. Forty-seven of these defects were small and contained, presenting little problem. Twenty defects were either large, contained, or peripheral, requiring reconstruction. Fifteen knees were lost as a result of death (but there had been satisfactory knee function); 2 were lost to follow-up evaluation, and 3 have required further revision. Seventy-nine percent of the surviving knees had excellent or good knee function at an average follow-up period of 56 months.

Entities:  

Mesh:

Year:  1998        PMID: 9526213     DOI: 10.1016/s0883-5403(98)90098-5

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  15 in total

1.  The Oxford unicompartmental knee prosthesis: an independent 10-year survival analysis.

Authors:  Peter Vorlat; Guy Putzeys; Dominique Cottenie; Tom Van Isacker; Nicole Pouliart; Frank Handelberg; Pierre-Paul Casteleyn; Filip Gheysen; René Verdonk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2005-05-14       Impact factor: 4.342

Review 2.  [Revision of unicompartmental knee arthroplasty].

Authors:  S Kirschner; J Lützner; S Fickert; K-P Günther
Journal:  Orthopade       Date:  2006-02       Impact factor: 1.087

3.  The clinical outcome of revision knee replacement after unicompartmental knee arthroplasty versus primary total knee arthroplasty: 8-17 years follow-up study of 49 patients.

Authors:  Jaakko Järvenpää; Jukka Kettunen; Hannu Miettinen; Heikki Kröger
Journal:  Int Orthop       Date:  2009-05-27       Impact factor: 3.075

4.  Lateral tibial plateau autograft in revision surgery for failed medial unicompartmental knee arthroplasty.

Authors:  Simone Cerciello; Brent Joseph Morris; Sebastien Lustig; Enrico Visonà; Giuliano Cerciello; Katia Corona; Philippe Neyret
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-04-24       Impact factor: 4.342

Review 5.  [Revision after unicompartmental knee arthroplasty].

Authors:  G Mohr; J Martin; M Clarius
Journal:  Orthopade       Date:  2014-10       Impact factor: 1.087

6.  Unicompartmental Knee Arthroplasty Revision to TKA: Are Tibial Stems and Augments Associated With Improved Survivorship?

Authors:  Peter L Lewis; David C Davidson; Stephen E Graves; Richard N de Steiger; William Donnelly; Alana Cuthbert
Journal:  Clin Orthop Relat Res       Date:  2018-04       Impact factor: 4.176

7.  Revision of 33 unicompartmental knee prostheses using total knee arthroplasty: strategy and results.

Authors:  Dominique Saragaglia; Gilles Estour; Charbel Nemer; Pierre-Emmanuel Colle
Journal:  Int Orthop       Date:  2008-06-18       Impact factor: 3.075

8.  Outcome of revision of unicompartmental knee replacement.

Authors:  Jacqueline R Hang; Tyman E Stanford; Stephen E Graves; David C Davidson; Richard N de Steiger; Lisa N Miller
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

9.  Results of a French multicentre retrospective experience with four hundred and eighteen failed unicondylar knee arthroplasties.

Authors:  Dominique Saragaglia; Michel Bonnin; David Dejour; Gérard Deschamps; Christophe Chol; Benoit Chabert; Ramsay Refaie
Journal:  Int Orthop       Date:  2013-05-29       Impact factor: 3.075

10.  Revision after early aseptic failures in primary total knee arthroplasty.

Authors:  Sérgio Rocha Piedade; Alban Pinaroli; Elvire Servien; Philippe Neyret
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-12-11       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.